EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Zinc Supplementation Enhances the Hematopoietic Activity of Erythropoiesis-Stimulating Agents but Not Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitors

Akira Takahashi iD

Nutrients · 2024

DOI: 10.3390/nu16040520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Akira Takahashi. Beteiligte Einrichtung: Dialysis Center, Tesseikai Neurosurgical Hospital, Shijonawate 575-8511, Japan. Hauptthemen laut MEDLINE: Hematinics, Anemia, Prolyl-Hydroxylase Inhibitors, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since zinc is involved in many aspects of the hematopoietic process, zinc supplementation can reduce erythropoiesis-stimulating agents (ESAs) in patients undergoing hemodialysis. However, it remains unclear whether hypoxia-inducible factor–prolyl hydroxylase inhibitors (HIF-PHIs) have similar reduction effects. HIF-PHI stabilizes HIF, which promotes hematopoiesis, although HIF-1α levels are downregulated by zinc. This study aimed to investigate the effect of zinc supplementation on the hematopoietic effect of HIF-PHI in patients undergoing hemodialysis. Thirty patients undergoing maintenance hemodialysis who underwent periods of treatment with roxadustat or darbepoetin alfa during the past 3 years were retrospectively observed. Participants who underwent periods with and without zinc supplementation were selected, with nine treated with darbepoetin alfa and nine treated with roxadustat. Similarly to the ESA responsiveness index (ERI), the hematopoietic effect of zinc supplementation was determined by the HIF-PHI responsiveness index (HRI), which was calculated by dividing the HIF-PHI dose (mg/week) by the patient’s dry weight (kg) and hemoglobin level (g/L). Zinc supplementation significantly increased ERI (p < 0.05), but no significant change was observed (p = 0.931) in HRI. Although zinc supplementation did not significantly affect HRI, adequate zinc supplementation is required to alleviate concerns such as vascular calcification and increased serum copper during the use of HIF-PHI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HematinicsAnemiaProlyl-Hydroxylase InhibitorsRenal Insufficiency, ChronicHumansZincErythropoiesisProlyl HydroxylasesDarbepoetin alfaRetrospective StudiesGlycineDietary Supplements

Stichwörter der Autor:innen

erythropoiesis-stimulating agenterythropoiesis-stimulating agent responsiveness indexhemodialysishypoxia-inducible factor–prolyl hydroxylase inhibitorsrenal anemiazinc deficiency

Substanzen

HematinicsProlyl-Hydroxylase InhibitorsZincProlyl HydroxylasesDarbepoetin alfaGlycine

Autor:innen und Institutionen

  • Dialysis Center, Tesseikai Neurosurgical Hospital, Shijonawate 575-8511, Japan.

ORCID-Profile: Akira Takahashi

Zitieren

APA

Takahashi, A. (2024). Zinc Supplementation Enhances the Hematopoietic Activity of Erythropoiesis-Stimulating Agents but Not Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitors. Nutrients. https://doi.org/10.3390/nu16040520

Vancouver

Takahashi A. Zinc Supplementation Enhances the Hematopoietic Activity of Erythropoiesis-Stimulating Agents but Not Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitors. Nutrients. 2024. doi:10.3390/nu16040520

BibTeX
@article{Takahashi2024,
  author = {Takahashi, Akira},
  title = {Zinc Supplementation Enhances the Hematopoietic Activity of Erythropoiesis-Stimulating Agents but Not Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitors},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16040520}
}
Kostenlos starten →